Back to Search
BRUCE MINSKY, MD
MD
Radiation Oncology Physician
NPI: 1114907789Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
036.117414(IL)
Research & Publications (20)
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).
PMID 19595467·Radiother Oncol·2009
8-other
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis.
PMID 19586672·Radiother Oncol·2009
1-meta
Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer.
PMID 19387328·Ann Surg·2009
8-other
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
PMID 19273696·J Clin Oncol·2009
3-trial
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
PMID 19212176·Ann Surg·2009
8-other
Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
PMID 18180997·Dis Colon Rectum·2008
4-observational
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
PMID 18362367·J Clin Oncol·2008
8-other
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
PMID 18442099·Cancer·2008
8-other
Multidisciplinary management of resectable rectal cancer. New developments and controversies.
PMID 19086601·Oncology (Williston Park)·2008
6-review
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
PMID 17878176·Ann Oncol·2008
3-trial
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007.
PMID 18539618·Ann Oncol·2008
8-other
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience.
PMID 17947223·Ann Oncol·2008
8-other
Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
PMID 17919844·Int J Radiat Oncol Biol Phys·2008
3-trial
Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy.
PMID 18046561·Int J Colorectal Dis·2008
4-observational
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
PMID 18574157·J Clin Oncol·2008
3-trial
Extended perineal resection of distal rectal cancers: surgical advance, increased utilization of neoadjuvant therapies, proper patient selection or all of the above?
PMID 18541898·J Clin Oncol·2008
8-other
The use of capecitabine in the combined-modality therapy for rectal cancer.
PMID 18501068·Clin Colorectal Cancer·2008
6-review
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
PMID 17882490·Ann Surg Oncol·2008
3-trial
Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum.
PMID 18605770·Arch Pathol Lab Med·2008
6-review
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
PMID 18202411·J Clin Oncol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD
HOUSTON, TX 77210 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1114907789
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile